Taking place at Thamrin, South Jakarta, STARmeds organized one-day activities with PEMO (Working Group on Drug Quality Estimation) as the first agenda, followed by the study dissemination afterwards on October 4, 2023. At PEMO, one of the topics discussed was input and responses from stakeholders related to the sustainability of the study and the implementation of study lessons learned. Also, the topic related to health data management, especially drugs at the national level, which needs to be the government’s attention. In addition, the dissemination aimed at sharing the results of the three-year study, what policy lessons were learned from this study and joint discussions with stakeholders related to drug quality. This agenda was attended by Bappenas, Kemenkes, BPOM, BPJS Kesehatan, LKPP, BPS, IAI, GP Farmasi, IPMG, BPS, WHO, GIZ, TBI, Irish Embassy, Equilab, NIHR, and others.